Table 2. Study’s reference interval defined as percentiles.
| Age, years | Percentile | |||||||
|---|---|---|---|---|---|---|---|---|
| Analyte (unit) | total | stratified | N | 2.5th | 5th | 50th | 95th | 97.5th |
| 20-45* | 3455 | 2.77 | 3.22 | 6.31 | 10.74 | 11.50 | ||
| DHEAS (µmol/L) | 20-25† | 842 | 3.65 | 4.16 | 7.4 | 11.79 | 12.76 | |
| 25-35* | 1627 | 2.97 | 3.32 | 6.37 | 10.64 | 11.50 | ||
| 35-45† | 990 | 2.30 | 2.71 | 5.41 | 9.03 | 9.83 | ||
| 20-45† | 518 | 2.48 | 2.83 | 5.13 | 8.20 | 8.89 | ||
| Androstenedione (nmol/L) | 20-30† | 267 | 3.02 | 3.38 | 5.76 | 8.75 | 9.43 | |
| 30-45† | 250 | 2.23 | 2.54 | 4.51 | 7.16 | 7.75 | ||
| DHEAS and androstenedione are calculated as total reference interval (RI) and with stratified age groups. RIs are defined with 5th and 95th percentile (90%RIs) and with 2.5th and 97.5th percentile (95%RIs). Median is 50th percentile. *Non-parametric percentile method. †Parametric method after Box-Cox transformation. DHEAS – dehydroepiandrostenedione sulphate. | ||||||||